The Washington Medical Commission said Guito Wingfield, MD, who is based in Centralia, prescribed the drug without documenting sufficient rationale, without informing the patient that the medication was off-label and without performing an appropriate risk analysis.
The order restricts Dr. Wingfield from prescribing ivermectin for non-FDA-approved indications and from prescribing medication or providing care without first establishing a physician-patient relationship, the report said.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
